Fifty top lawyers of major corporations, including Big Pharma, Big Insurance and Big Tech, are urging the federal court system to clarify a rule of evidence that sets standards on expert testimony.

The lawyers, primarily chief legal officers and general counsel, sent a joint letter Monday to the Advisory Committee on Evidence Rules, which is looking at how federal courts address expert testimony and is exploring whether to amend the procedural rule, known as Rule 702.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]